Amicus Therapeutics Inc. buy UBS Group AG
Start price
02.03.23
/
50%
€12.00
Target price
02.03.24
€16.05
Performance (%)
0.83%
End price
03.03.24
€12.10
Summary
This prediction ended on 03.03.24 with a price of €12.10. The BUY prediction by UBS_Group_AG for Amicus Therapeutics Inc. closed nearly unchanged. UBS_Group_AG has a follow-up prediction for Amicus Therapeutics Inc. where he still thinks Amicus Therapeutics Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Amicus Therapeutics Inc. | -0.526% | -0.526% | -8.252% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by UBS_Group_AG for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at UBS Group AG from $15.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.60
10.05.24
10.05.24
€17.63
10.05.25
10.05.25
12.21%
03.10.24
03.10.24